Tuberculosis News and Research

Latest Tuberculosis News and Research

Study proposes new approach that cures multidrug-resistant TB in conflict-affected communities

A high proportion of multidrug-resistant tuberculosis cases can be cured in conflict-affected communities with molecular diagnostics, shorter treatment periods and socioeconomic incentives, according to the results of a large, long-term study in the Democratic Republic of Congo led by the University of Pittsburgh Graduate School of Public Health and Stellenbosch University in South Africa, in collaboration with the DRC National Tuberculosis Program.

14 Feb 2019

GenoScreen’s Deeplex-MycTB test could help define appropriate treatment for tuberculosis patients

The new Deeplex®-MycTB mycobacterial antibiotic resistance test1, developed by GenoScreen, has been used by an international research team in a molecular epidemiology study published in The Lancet Infectious Diseases.

13 Feb 2019

Inhibiting tuberculosis-induced cell death with immunotherapy

Tuberculosis treatment still entails the intake several antibiotics over a period of many months and is torturous for many patients. The pathogen's increasing multidrug resistance additionally complicates this lengthy treatment, and side effects frequently lead to a discontinuation of treatment and high mortality rates.

12 Feb 2019

Inaccurate tests carried out on tuberculosis patients lead to high mortality rate

Inaccurate tests carried out on tuberculosis patients in developing countries often fail to reliably detect resistance to drugs, leading to incorrect treatment and a higher mortality rate.

8 Feb 2019

Vitamin D helps clear bacteria from lungs of people with multi-drug resistant TB

Vitamin D has been found to speed up the clearance of tuberculosis bacteria from the lungs of people with multi-drug resistant TB, according to a study of 1,850 patients receiving antibiotic treatment, led by Queen Mary University of London.

6 Feb 2019

New research collaboration between EU and Russia focuses on infectious diseases

A new EU project on the theme of HIV, hepatitis C and tuberculosis is a door opener for collaboration between researchers from EU countries and Russia.

28 Jan 2019

'Antibiotic-Resistant Genes' found in one of the last pristine places on earth

Antibiotic-Resistant Genes that were first detected in urban India have been found 8,000 miles away in one of the last 'pristine' places on earth, a new study has shown.

28 Jan 2019

New analysis highlights need for rigorous evidence to back up 'The Global Fund' impact claims

The Global Fund to Fight AIDS, Tuberculosis and Malaria ('The Global Fund') asserts they and their partners have saved 27 million lives—but more rigorous evidence and data is needed to back up that claim, according to a new analysis published in The Lancet this week.

25 Jan 2019

Researchers understand reproductive behaviors and olfactory abilities of African pouched rat

Thousands of people - many of them children - are hurt or killed by land mines each year, so finding these devices before they explode is critical.

25 Jan 2019

African scientists to build research capacity in African countries, develop ongoing scientific partnerships

Ten African scientists have been selected for training at the National Institutes of Health as part of a new fellowship program to build research capacity in African countries and develop ongoing scientific partnerships.

24 Jan 2019

CMV vaccine provides a new way to fight malaria

Early research on a new approach to protecting against malaria is offering promising, potentially long-lasting results against the persistent parasite that sickens hundreds of millions people each year.

24 Jan 2019

LJI awarded $22 million contract renewal to host and expand Immune Epitope Database

La Jolla Institute for Immunology has been awarded a $22 million contract renewal over seven years from the National Institutes of Health to host and expand the Immune Epitope Database.

24 Jan 2019

Clinical testing begins for temperature-stable experimental tuberculosis vaccine

Vaccinations have begun in a Phase 1 human clinical trial testing a freeze-dried, temperature-stable formulation of an experimental tuberculosis vaccine candidate.

23 Jan 2019

Migrants and refugees do not bring disease and are at greater health risk themselves says WHO

The irregular migrant refugees coming to European nations are often accused on bringing with them host of exotic communicable diseases that tend to spread among the host communities. The World Health Organization (WHO) this week has absolved the migrants of spreading disease in its first report that deals with this issue.

22 Jan 2019

Peptide isolated from soil fungi has antitumor and antibacterial properties

A team of scientists from I.M. Sechenov First Moscow State Medical University together with their colleagues isolated a peptide named emericellipsin A from soil fungi.

22 Jan 2019

New resource-based approach to improve HIV care in low- and middle-income countries

A practical resource-based public health approach for the rapid initiation of antiretroviral therapy in HIV-infected individuals living in low- and middle-income countries could save thousands of lives, according to an Essay published January 15 in the open-access journal PLOS Medicine by Mark Tenforde of the University of Washington School of Medicine, and colleagues.

18 Jan 2019

New rapid blood tests could speed up TB diagnosis, save the NHS money

Rapid blood tests used by the NHS are unable to rule out tuberculosis (TB) and should be replaced with a new, more accurate test, a study has found.

17 Jan 2019

Scientists solve another piece of Ebola virus puzzle

A team of researchers have discovered the interaction between an Ebola virus protein and a protein in human cells that may be an important key to unlocking the pathway of replication of the killer disease in human hosts.

17 Jan 2019

Study offers new insight on mechanism underlying control of gene expression

Researchers have provided new insight on the mechanism underlying the control of gene expression in all living organisms, according to a study published today in eLife.

8 Jan 2019

Rockefeller scientists uncover genetic mutation responsible for tuberculosis vulnerability

If you live in the United States, you are unlikely to come into contact with the microbe that causes tuberculosis. Your odds of encountering the microbe are so low, in fact, that risk factors for the disease can easily go unnoticed: If you happened to carry a gene that predisposed you to tuberculosis, you likely wouldn't know.

2 Jan 2019

Tuberculosis News and Research

Latest Tuberculosis News and Research

Study proposes new approach that cures multidrug-resistant TB in conflict-affected communities

GenoScreen’s Deeplex-MycTB test could help define appropriate treatment for tuberculosis patients

Inhibiting tuberculosis-induced cell death with immunotherapy

Inaccurate tests carried out on tuberculosis patients lead to high mortality rate

Vitamin D helps clear bacteria from lungs of people with multi-drug resistant TB

New research collaboration between EU and Russia focuses on infectious diseases

'Antibiotic-Resistant Genes' found in one of the last pristine places on earth

New analysis highlights need for rigorous evidence to back up 'The Global Fund' impact claims

Researchers understand reproductive behaviors and olfactory abilities of African pouched rat

African scientists to build research capacity in African countries, develop ongoing scientific partnerships

CMV vaccine provides a new way to fight malaria

LJI awarded $22 million contract renewal to host and expand Immune Epitope Database

Clinical testing begins for temperature-stable experimental tuberculosis vaccine

Migrants and refugees do not bring disease and are at greater health risk themselves says WHO

Peptide isolated from soil fungi has antitumor and antibacterial properties

New resource-based approach to improve HIV care in low- and middle-income countries

New rapid blood tests could speed up TB diagnosis, save the NHS money

Scientists solve another piece of Ebola virus puzzle

Study offers new insight on mechanism underlying control of gene expression

Rockefeller scientists uncover genetic mutation responsible for tuberculosis vulnerability

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in